Sales of Platelet Aggregation Devices Market is projected to increase at a CAGR of 20% through 2027

The global platelet aggregation devices market (血小板凝集装置市場), currently valued at US$ 421 million, is expected to exceed US$ 1 billion by the end of 2027. This remarkable growth is attributed to the projected increase in worldwide demand for these devices, with a forecasted compound annual growth rate (CAGR) of 20% during the period 2022-2027.

Market Dynamics

Platelet aggregation devices play a crucial role in assessing platelet function, aiding in the diagnosis and management of various bleeding disorders and cardiovascular diseases. The market for these devices is primarily driven by the rising prevalence of cardiovascular diseases, increasing demand for point-of-care testing, and advancements in healthcare infrastructure. Moreover, the growing geriatric population globally, which is more prone to cardiovascular ailments, further fuels the market growth.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7657

Technological advancements have led to the development of compact, user-friendly platelet aggregation devices, which offer rapid and accurate results. These devices enable healthcare professionals to make timely decisions regarding patient treatment, thereby enhancing patient care and clinical outcomes. Additionally, the integration of automation and digitalization in platelet aggregation testing has streamlined the process, reducing the turnaround time and improving overall efficiency.

List of Key Companies Profiled in The Report

Aggredyne Inc.
Helena Laboratories Corporation
Bio/Data Corporation
Chrono-Log Corporation
F. Hoffmann-La Roche Ltd.
Instrumentation Laboratory
Haemonetics Corporation
Siemens Healthcare GmbH
SENTINEL CH. SpA
Werfen
Pathway Diagnostics Limited
Haemochrom Diagnostica GmbH
Tem Group

Market Future Outlook

The platelet aggregation devices market (혈소판 응집 장치 시장) is poised for significant growth in the coming years, driven by ongoing research and development activities aimed at enhancing the performance and functionality of these devices. The introduction of novel biomarkers and assays for platelet function testing is expected to further propel market growth. Furthermore, the expanding application of platelet aggregation testing beyond cardiovascular diseases, such as in oncology and autoimmune disorders, presents lucrative opportunities for market players.

As healthcare systems worldwide focus on preventive care and early disease detection, the demand for point-of-care platelet aggregation devices is expected to surge. These devices offer the advantage of rapid testing at the patient's bedside or in outpatient settings, facilitating timely intervention and personalized treatment strategies. Moreover, the growing adoption of home healthcare solutions and remote monitoring technologies is likely to drive the demand for portable and easy-to-use platelet aggregation devices.

Market Insights

North America currently dominates the platelet aggregation devices market, owing to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and technological advancements in the region. However, Asia Pacific is expected to witness the fastest growth during the forecast period, fueled by increasing healthcare expenditure, rising awareness about preventive care, and expanding access to healthcare services in emerging economies such as China and India.

Want Full Report? Enquire Here- https://www.factmr.com/report/platelet-aggregation-devices-market

Recent Developments

Manufacturers in the platelet aggregation devices market (marché des dispositifs d'agrégation plaquettaire) are anticipated to prioritize the introduction of innovative products to enhance their sales potential and gain a competitive advantage.

For instance, in July 2021, Sysmex Corporation, a prominent player in the global platelet aggregation devices market, unveiled its latest automated blood coagulation analyzers, the CN-3500 and CN-6500. These analyzers are designed to measure platelet aggregation parameters and blood coagulation in the fields of hemostasis and thrombosis.

Similarly, Futura Surgicare Pvt. Ltd., a manufacturer of wound closure devices, expanded its product portfolio in February 2022 with the launch of new hemostatic products. Among these, Hemostax Standard stands out as a hemostat that enables surgeons to manage bleeding more effectively.

Explore More Related Studies Published by Fact.MR Research:

Human Platelet Lysate Market (인간 혈소판 용해물 시장): https://www.factmr.com/report/human-platelet-lysate-market

Platelet-Rich Plasma Market (Marché du plasma riche en plaquettes): https://www.factmr.com/report/170/platelet-rich-plasma-market

Anti-Platelet Agents Market (抗血小板薬市場): https://www.factmr.com/report/anti-platelet-agents-market

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.